Corcept Therapeutics
CORT
#2425
Rank
โ‚น692.13 B
Marketcap
โ‚น6,324
Share price
-3.25%
Change (1 day)
-4.92%
Change (1 year)

EPS for Corcept Therapeutics (CORT)

EPS in 2026 (TTM): โ‚น142.80

According to Corcept Therapeutics 's latest financial reports the company's current EPS (TTM) is โ‚น139.94. In 2025 the company made an earnings per share (EPS) of โ‚น87.69 a decrease over its 2024 EPS that were of โ‚น125.94.

EPS history for Corcept Therapeutics from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น142.8062.85%
2025โ‚น87.69-30.37%
2024โ‚น125.94
2022โ‚น88.63-2.06%
2021โ‚น90.495.43%
2020โ‚น85.8310.84%
2019โ‚น77.4327.69%
2018โ‚น60.64-42.48%
2017โ‚น105.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น623.16 345.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น489.77 250.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น66.24-52.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,882 1,959.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น92.64-33.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น421.67 201.33%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-โ‚น12.13-108.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น1.87-101.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-โ‚น8.40-106.00%๐Ÿ‡บ๐Ÿ‡ธ USA